Private equity firm Bain Capital (BCSF) is paying $3.4 billion to buy a 350-year-old Japanese drugs group fighting diabetes ...

Sumitomo Mitsui Trust Group Inc. lessened its holdings in shares of Bain Capital Specialty Finance, Inc. (NYSE:BCSF – Free Report) by 1.4% in the 4th quarter, according to its most recent Form 13F ...

TOKYO (Reuters) - U.S. private equity firm Bain Capital said it may withdraw its tender offer proposal for Japanese IT firm ...

Bain Capital is nearing a deal to buy Mitsubishi Chemical Group Corp.’s pharmaceutical unit, people familiar with the matter ...

Brentwood, Tenn.-based Surgery Partners received a nonbinding acquisition proposal from Bain Capital Private Equity on Jan. 27, offering to buy all outstanding shares for $25.75 per share in cash.

In a notable performance, Bain Capital Specialty Finance (NYSE:BCSF) stock has reached a 52-week high, touching $17.27. This peak reflects a significant uptrend for the company,... Bain Capital ...

SelectQuote shares surged 33% in premarket trading a day after it secured a $350 million investment from funds managed by Bain Capital, Morgan Stanley Private Credit, and Newlight Partners. Shares ...

Advent International, Bain Capital, EQT AB and KKR are candidates for a takeover of Japan's Trend Micro. The security company has been considering ...

Apleona is a European provider of integrated facility management. Bain Capital has acquired Apleona from PAI Partners.

Bain Capital will partner with Milacron’s current owner ... or results of the Proposed Transaction on the market price of the Hillenbrand’s common stock; and risks related to diversion of management’s ...

In a statement, Bain said that it is 'carefully considering' its future policy, including 'the option of withdrawing' its ...